Diabetes Diagnostic & Monitoring Markets with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024

Diabetes Diagnostic & Monitoring Markets with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024

Report Overview:

Will diabetes management become a diabetes cure? Diabetes management is moving onto phones and laptops and integrated into physicians’ databases. Well established players are jockeying for position in this emerging digital environment while the fundamentals suggest global growth that will continue well into the future. The results of these efforts will change what diabetes means to millions of people worldwide. The digital revolution is breathing new life into the commodity world of testing strips. Understand what is driving this huge global diagnostic market.

Our facts and support = Your success.

The report forecasts the market size out to 2024. Growth is coming from the fundamentals and the move to real time data management of blood parameters. When does effective management constitute a cure? New technologies are bringing an artificial pancreas into view. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Digital Diagnostics are merging with spectacular success.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.


1. Introduction and Market Definition
1.1 An Overview of Diagnostics and Monitoring of Diabetes
1.2 Diabetes Prevalence – the Big Picture
Table: Diabetes Prevalence by Region
Figure: Diabetes Global Prevalence Map
Figure: Prevalence by Income Group and Age
1.2.1 Undiagnosed Diabetes – The Opportunity
Figure: Undiagnosed Cases by Region
1.2.2 Prevalence Increasing – the Drivers and the Implications
Figure: Reasons for Increasing Prevalence
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.3.4 Glucose Assay
1.3.5 HbA1c Assay
1.3.6 Continuous Glucose Monitoring
1.3.7 Laboratory Assay
1.3.8 Point of Care Hospital
1.3.9 Point of Care Consumer
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing
2. Diabetes – Current Science
2.0 Understanding the Disease
2.1 Type 1
2.1.1 Causes
2.1.2 Diagnosis
2.2 Type 2
2.2.1 Causes
2.2.2 Diagnosis
2.3 Diabetes Related Disease
2.3.1 Cardiovascular
2.3.2 Renal
2.3.3 Neuropathy
2.3.4 Eye Damage/Vision Loss
2.3.5 Stroke and Dementia
2.3.6 Sexual dysfunction/pregnancy
2.3.7 Infection and Other
2.3.8 Diabetic Ketoacidosis
2.4 Pancreas and Autoimmunity
2.4.1 Role of Pancreas
2.4.2 Autoimmunity
3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Pharmaceutical/Reagent Supplier
3.1.4 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body
4. Market Trends
4.1 Factors Driving Growth
4.1.1 Increasing Prevalence
4.1.2 Obesity Epidemic
4.1.3 Rapid Low Cost Diagnositics
4.1.4 Wellness and Health Management
4.1.5 Move to Point of Care
4.1.6 Developing World Health Care Spending
4.2 Factors Limiting Growth
4.2.1 The Cost Curve Shrinks the Market
4.2.2 The Diagnostics Dillemma
4.2.3 Systemic Roadblocks
4.3 Diagnostic Technology Development
4.3.1 The Screening Opportunity
4.3.2 Shifting Role of Physicians in Diagnosis
4.3.3 Diagnostics Moves Out of the Lab
4.3.4 The Diabetes Management Apps
4.3.5 From Monitor to Pumps – Strategic Partnership Plays
4.3.6 The Next Five Years
5. Diabetes Diagnostics - Recent Developments
5.1 Recent Developments – Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Diabetes app Glucose Buddy supports Dexcom CGM devices
ABBOTT'S FREESTYLE® LIBRE 2 SECURES CE MARK
Siemens Healthineers and Hill-Rom to Provide Comprehensive Diabetes Care
Trividia Health, Inc. to acquire Freedom Meditech
Medtronic to Acquire Nutrino Health
Nova Biomedical Receives FDA Clearance for Capillary Testing with Critically Ill Patients
ARKRAY announces new blood glucose monitoring systems.
Life365 Extends Connected Care Platform Partnership with OSANG Healthcare
AgaMatrix Enters Strategic Partnership with Arcadia Group
PTS Diagnostics Updated System, Lowers Average Cost Per Test
ACON Laboratories Launches New System for the Veterinary Market
Senseonics extends distribution agreement with Roche Diabetes Care
Ascensia Diabetes Care Announces Global Partnership with Poctech
New Release of OneTouch Reveal® Mobile App
J&J to sell Lifescan, dropping out of diabetes diagnostics
6. Profiles of Key Companies
A.Menarini Diagnostics Ltd.
Acon Laboratories, Inc.
AgaMatrix, Inc.
Agilent (Dako)
Apex Biotechnology Corporation
ARKRAY, Inc.
Ascensia Diabetes Care Holdings AG
B. Braun Melsungen AG
Becton, Dickinson & Co.
Beckman Coulter, Inc.
BIONIME Corporation
Bio-Rad Laboratories
Danaher Corporation
DexCom, Inc.
Diazyme Laboratories Inc.
EKF Diagnostics Holdings Plc
HemoCue® AB
LifeScan, Inc.
Medtronic PLC
Nipro Europe
Nova Biomedical Corporation
OSANG Healthcare Co., Ltd.
Pepex Biomedical
PTS Diagnostics
Roche Diabetes Care, Inc.
Sanofi S.A.
Sanwa Kagaku Kenkyusho Co, Ltd.
Siemens Healthineers
Sinocare, Inc.
Trividia Health, Inc.
TaiDoc Technology Corporation
Tandem Diabetes Care, Inc.
Terumo Corporation
Thermo Fisher Scientific
Tosoh Bioscience, Inc.
Trinity Biotech plc
Ypsomed AG
7. Diabetes Diagnostic Markets
7.1 DIABETES DIAGNOSTICS – Global Market Overview by Country
7.1.1 Table – Global Market by Country
7.1.2 Chart - Global Market by Country
8. Global DIABETES DIAGNOSTICS Markets – By Assay
8.1 Global Market by Assay - Overview
8.1.1 Table – Global Market by Assay
8.1.2 Chart – Global Market by Assay – 2019/2024 Comparison
8.1.3 Chart – Global Market by Assay – 2019
8.1.4 Chart – Global Market by Assay –2024
8.1.4 Chart – Global Market by Assay – Share by Year
8.2 DIABETES DIAGNOSTICS Glucose Assay
8.2.1 Table DIABETES DIAGNOSTICS Glucose – by Country
8.2.2 Chart - DIABETES DIAGNOSTICS Glucose Growth
8.2.3 Table DIABETES DIAGNOSTICS Glucose by Lab, PoC Hospital, PoC Consumer
8.2.4 Chart - DIABETES DIAGNOSTICS Glucose Growth by Lab, PoC Hospital, PoC Consumer
8.3 DIABETES DIAGNOSTICS HbA1c Assay
8.3.1 Table DIABETES DIAGNOSTICS HbA1c– by Country
8.3.2 Chart - DIABETES DIAGNOSTICS HbA1c Growth
8.3.3 Table DIABETES DIAGNOSTICS HbA1c by Lab, PoC Hospital, PoC Consumer
8.3.4 Chart - DIABETES DIAGNOSTICS HbA1c Growth by Lab, PoC Hospital, PoC Consumer ..
8.4 DIABETES DIAGNOSTICS Continuous Glucose Monitoring
8.4.1 Table DIABETES DIAGNOSTICS Continuous Glucose Monitoring – by Country
8.4.2 Chart - DIABETES DIAGNOSTICS Continuous Glucose Monitoring Testing Growth
Appendices
I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule – National Limit and
Midpoint
Table of Tables
Table 1 Diabetes Prevalence by Region
Table 2 Lab Spending 2014 to 2024
Table 3 Market Players by Type
Table 4 Five Factors Driving Growth
Table 5 Three Factors Limiting Growth
TABLE 6 - GLOBAL DIABETES DIAGNOSTICS MARKET BY REGION
TABLE 7 GLOBAL MARKET BY ASSAY
TABLE 8 DIABETES DIAGNOSTICS GLUCOSE BY COUNTRY
TABLE 9 DIABETES DIAGNOSTICS GLUCOSE BY LAB, POC HOSPITAL, POC CONSUMER
TABLE 10 DIABETES DIAGNOSTICS HBA1C BY COUNTRY
TABLE 11 DIABETES DIAGNOSTICS HBA1C BY LAB, POC HOSPITAL, POC CONSUMER
TABLE 12 DIABETES DIAGNOSTICS CONTINUOUS GLUCOSE MONITORING BY COUNTRY
Table 13 2018 Clinical Lab Fee Schedule
Table of Figures
Figure 1 Diabetes Global Prevalence Map
Figure 2 Prevalence by income Group and Age
Figure 3 Undiagnosed Cases by Region
Figure 4 Reasons for Increasing Prevalence
Figure 5 Clinical Lab Spending 2014 to 2024
Figure 6 Obesity Prevalence Map of USA
Figure 7 Growth in Health Care Spending Developing World
Figure 8 Comparing The New Diagnostics and Traditional Testing
Figure 9 Growth rates of Diabetes Diagnostics
Figure 10 2018 Global Market Density Chart
Figure 11 DIABETES DIAGNOSTICS Market by Assay - 2019 vs. 2024
FIGURE 12 DIABETES DIAGNOSTICS MARKET 2019
FIGURE 13 DIABETES DIAGNOSTICS MARKET 2024
FIGURE 14 ASSAY SHARE BY YEAR
FIGURE 15 DIABETES DIAGNOSTICS HBA1C GROWTH
FIGURE 16 DIABETES DIAGNOSTICS GLUCOSE GROWTH
FIGURE 17 DIABETES DIAGNOSTICS HBA1C GROWTH
FIGURE 18 DIABETES DIAGNOSTICS HBA1C GROWTH
FIGURE 19 DIABETES DIAGNOSTICS CONTINUOUS GLUCOSE MONITORING TESTING GROWTH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook